Login
Home
About Us
Services
Advances & More News
Medical News
Contact Us
Medical News
From ESC 2023: Bempedoic Acid Proves Cardiovascular Benefit Across Glycemic Spectrum in New Analysis
Data from an analysis of the landmark CLEAR Outcomes trial suggests bempedoic acid could prove useful ...
read more
Reporting from ESC 2023: New Evidence, Guidelines Support Mavacamten Use in Hypertrophic Cardiomyopathy
At the European Society of Cardiology (ESC) Congress 2023, the spotlight was on mavacamten and its ...
read more
Broadcasting from ESC 2023: Mavacamten Use Can Reduce Need for Septal Reduction Therapy in oHCM
Data from VALOR-HCM LTE suggest use of the cardiac myosin inhibitor mavacamten (Camzyos) could reduce the ...
read more
From ESC congress 2023 - FRAIL-AF: Switching to NOACs in Older, Frail Patients Linked to Increased Bleeding Risk
For frail elderly patients with atrial fibrillation, switching from a vitamin K antagonist (VKA) treatment to ...
read more
Newly reported from ESC 2023 - Diabetes Dialogue: STEP-HFpEF Reaction
For endocrinologists and the diabetes care team, GLP-1 receptor agonists have been a familiar face for ...
read more
Directly from ESC 2023: Acoramidis Reduces All-Cause, Cardiovascular Mortality at 30 Months in ATTR-CM
The 30-month results of the phase 3 ATTRibute-CM trial provide the latest insight into the effects ...
read more
Reporting from ESC 2023: Semaglutide for HFpEF? Breaking Down the STEP-HFpEF Trial, with Javed Butler, MD
The understanding and management of heart failure with preserved ejection fraction (HFpEF) has undergone a transformation ...
read more
Role of Intravenous Iron in Spotlight At ESC Congress 2023
A pair of studies and focused guideline update from the European Society of Cardiology (ESC) Congress ...
read more
1
2
3
4
5
...
Next
Last